News Release

TAIFEX, CME to Sign Memorandum of Understanding

Thu Oct 26 2006

CHICAGO, Oct. 26 /PRNewswire-FirstCall/ -- The Taiwan Futures Exchange (TAIFEX), a rising derivatives exchange in the Asia-Pacific Region and the only derivatives exchange in Taiwan, and CME, the world's largest and most diverse financial exchange, announced today that they are signing a Memorandum of Understanding (MOU) to establish a forum for information sharing between the two organizations.

"Asia is an important element of our global growth strategy," said CME Chairman Terry Duffy. "With this MOU, we hope to further develop our channels of communication and continue to foster our relationship with TAIFEX, a dynamic leader in the derivatives marketplace."

TAIFEX Chairman Dr. Rong-I Wu said, "The trend of globalization is forcing derivatives markets to face unprecedented competition. In addition to adjusting organizational structure and seeking market integration, exchanges are actively seeking international strategic alliances to form long-term growth strategies based on their core competencies. Through the exchange of information and the sharing of experiences, both exchanges can effectively tackle the challenge of internationalization by focusing on management efficiency, product development and market expansion to achieve a win-win situation."

The MOU will be signed by Dr. Wu and Phupinder Gill, President and Chief Operating Officer of CME. This is the ninth MOU to be signed by TAIFEX. Through the establishment of this cooperation platform with CME, which has the largest short-term interest rate futures market in the world, TAIFEX hopes to leverage on CME's experience in financial innovation and global expansion to actively participate in the global derivatives market.

"Signing this MOU with TAIFEX initiates a closer working relationship between our two exchanges and further expands our presence in Asia that began more than 20 years ago," said CME Chief Executive Officer Craig Donohue. "Through strengthened collaboration, we will learn from each others' experiences, gain additional insights into the diverse needs of our customers in the global marketplace and position ourselves to better understand and address the risk management needs of market users in this part of the world."

The signing ceremony will be held in the Far Eastern Plaza Hotel Taipei and will be witnessed by Dr. Shyan-Yuan Lee, a Commissioner at the Financial Supervisory Commission. "It is my sincere hope that both sides will derive the maximum benefit from their cooperation and that the relationship will make a major contribution to improve supervision of futures markets in both the U.S. and Taiwan," Dr. Lee said before the ceremony.


Since the launch of its first product (TAIEX Futures) in 1998, TAIFEX has experienced tremendous growth. According to FIA, as of June 2006, TAIFEX's trading volume was ranked 18th globally. The TAIEX Options, TAIFEX's flagship product, is the third-most actively traded stock index options contract in the world. TAIFEX currently offers 14 products, including futures and options on major Taiwan stock indices, government bond futures, 30-day commercial paper interest rate futures, equity options and gold futures. To further expand the market, TAIFEX has actively taken measures to facilitate internationalization and to boost foreign participation. On March 27 2006, TAIFEX launched three US dollar-denominated products, including TAIFEX Gold Futures, TAIFEX MSCI Taiwan Index(SM) Futures and TAIFEX MSCI Taiwan Index(SM) Options. In conjunction with the launch of these new products, TAIFEX has taken several liberalization measures. Among other measures, it now allows trading for non-hedging purposes by foreign investors, has introduced omnibus accounts, and accepts US dollar as margin deposit to keep in line with international practices.

About CME:

CME ( ) is the world's largest and most diverse financial exchange. As an international marketplace, CME brings together buyers and sellers on the CME Globex® electronic trading platform and on its trading floors. CME offers futures and options on futures in these product areas: interest rates, stock indexes, foreign exchange, agricultural commodities, energy, and alternative investment products such as weather, real estate and economic derivatives. CME is a wholly-owned subsidiary of Chicago Mercantile Exchange Holdings Inc. (NYSE: CME)(NASDAQ: CME), which is part of the Russell 1000® Index and the S&P 500® Index.

Statements in this news release that are not historical facts are forward-looking statements. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements. More detailed information about factors that may affect our performance may be found in our filings with the Securities and Exchange Commission, including our most recent Quarterly Report on Form 10-Q, which can be obtained at its Web site at . We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Chicago Mercantile Exchange, CME, the globe logo, CME Globex and E-mini are trademarks of Chicago Mercantile Exchange Inc. CLEARING 21 is a registered trademark of CME and New York Mercantile Exchange, Inc. S&P, S&P 500, NASDAQ-100, Nikkei 225, Russell 1000, Russell 2000, TRAKRS, Total Return Asset Contracts and other trade names, service marks, trademarks and registered trademarks that are not proprietary to Chicago Mercantile Exchange Inc. are the property of their respective owners, and are used herein under license. Further information about CME and its products is available on the CME Web site at .


SOURCE: Chicago Mercantile Exchange

CONTACT: Media, Taifax, 02 2369 5678, or , or
Allan Schoenberg, +1-312-930-8189, or Mary Haffenberg, +1-312-930-3435, or , both of CME, or Investors, John Peschier, +1-312-930-8491

Web site:

Corporate Communications

+1 312 930 3434